• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Markers of bile duct tumors.胆管肿瘤标志物。
World J Gastrointest Oncol. 2011 Apr 15;3(4):49-59. doi: 10.4251/wjgo.v3.i4.49.
2
Neuroendocrine tumor of the common bile duct: case report.胆总管神经内分泌肿瘤:病例报告
G Chir. 2016 Nov-Dec;37(6):275-280. doi: 10.11138/gchir/2016.37.6.275.
3
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.基质金属蛋白酶在肝内胆管癌、肝门部(克氏壶腹肿瘤)、肝外胆管中下段癌、胆囊癌和壶腹癌中的表达:基质金属蛋白酶在肿瘤进展和预后中的作用
Turk J Gastroenterol. 2009 Mar;20(1):41-7.
4
Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.紫藤凝集素唾液酸化粘蛋白核心多肽1是胆管癌和肝内胆管癌的敏感生物标志物:一项多中心研究。
J Gastroenterol. 2017 Feb;52(2):218-228. doi: 10.1007/s00535-016-1230-0. Epub 2016 Jun 29.
5
Evaluation of Tumor Markers and Their Impact on Prognosis in Gallbladder, Bile Duct and Cholangiocellular Carcinomas - A Pilot Study.胆囊、胆管和胆管细胞癌中肿瘤标志物的评估及其对预后的影响——一项初步研究
Anticancer Res. 2017 Apr;37(4):2003-2009. doi: 10.21873/anticanres.11544.
6
Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.检测血清癌胚抗原、糖类抗原19-9、细胞角蛋白-19片段和基质金属蛋白酶-7用于诊断胆管癌:一项初步病例对照研究
Anticancer Res. 2014 Nov;34(11):6663-7.
7
Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC).仅接受最佳支持治疗(BSC)的、体能状态(PS)良好的转移性胆管癌(BTC)患者的自然病程。
Jpn J Clin Oncol. 2015 Mar;45(3):256-60. doi: 10.1093/jjco/hyu210. Epub 2015 Jan 26.
8
Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.血清CYFRA 21-1在胆道癌中的作用:胆囊癌和肝内胆管癌的可靠生物标志物
Dig Dis Sci. 2015 May;60(5):1273-83. doi: 10.1007/s10620-014-3472-0. Epub 2014 Dec 9.
9
Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.用于检测胰胆恶性肿瘤的胆囊胆汁肿瘤标志物定量分析
Anticancer Res. 2000 Nov-Dec;20(6D):4941-7.
10
Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.肝细胞-胆管细胞癌合并症:一项组织病理学、免疫组织化学及原位杂交研究
Am J Surg Pathol. 2002 Aug;26(8):989-97. doi: 10.1097/00000478-200208000-00003.

引用本文的文献

1
Quantitative MRCP metrics as imaging biomarkers to differentiate benign from malignant bile duct obstructions.作为成像生物标志物的定量磁共振胰胆管造影(MRCP)指标用于鉴别良性与恶性胆管梗阻。
Front Oncol. 2025 May 6;15:1576163. doi: 10.3389/fonc.2025.1576163. eCollection 2025.
2
Establishment and characterization of a novel human gallbladder cancer cell line, GBC-X1.建立并鉴定一种新型人胆囊癌细胞系,GBC-X1。
Sci Rep. 2024 Sep 13;14(1):21439. doi: 10.1038/s41598-024-72830-0.
3
Current Status of Protein Biomarkers in Urolithiasis-A Review of the Recent Literature.尿路结石中蛋白质生物标志物的现状——近期文献综述
J Clin Med. 2023 Nov 16;12(22):7135. doi: 10.3390/jcm12227135.
4
Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?胆管癌中的同源重组修复:PARP抑制的主要靶点?
Cancers (Basel). 2022 May 23;14(10):2561. doi: 10.3390/cancers14102561.
5
Efficacy and Safety of Apatinib Treatment for Advanced Cholangiocarcinoma After Failed Gemcitabine-Based Chemotherapy: An Open-Label Phase II Prospective Study.吉西他滨为基础的化疗失败后阿帕替尼治疗晚期胆管癌的疗效和安全性:一项开放标签的II期前瞻性研究。
Front Oncol. 2021 May 3;11:659217. doi: 10.3389/fonc.2021.659217. eCollection 2021.
6
Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.从转移性胆囊癌肿瘤中分离出的三个新型细胞系的功能和基因组特征。
Biol Res. 2020 Apr 15;53(1):13. doi: 10.1186/s40659-020-00282-7.
7
Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases.血清无细胞 DNA 甲基化 OPCML 和 HOXD9 作为一种生物标志物,可能有助于胆管癌和其他胆道疾病的鉴别诊断。
Clin Epigenetics. 2019 Mar 4;11(1):39. doi: 10.1186/s13148-019-0634-0.
8
Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma.将HNF-1B作为胰腺导管腺癌诊断生物标志物的研究。
Biomark Res. 2018 Jul 27;6:25. doi: 10.1186/s40364-018-0139-6. eCollection 2018.
9
Dynamics of liver enzymes in rabbits experimentally infected with Fasciola sp. (Intermediate form from Japan).感染日本分体吸虫(中间型)的实验性家兔肝脏酶的动态变化
J Vet Med Sci. 2018 Jan 1;80(1):36-40. doi: 10.1292/jvms.17-0315. Epub 2017 Nov 9.
10
Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.源自一名意大利患者的人肝内胆管癌细胞系的建立与鉴定
Tumour Biol. 2016 Mar;37(3):4041-52. doi: 10.1007/s13277-015-4215-3. Epub 2015 Oct 20.

本文引用的文献

1
Serum markers of hepatocellular carcinoma.肝细胞癌的血清标志物。
Dig Dis Sci. 2010 Oct;55(10):2744-55. doi: 10.1007/s10620-010-1184-7. Epub 2010 Mar 26.
2
Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma.合并症会对肝外胆管癌患者的预后产生负面影响。
World J Gastroenterol. 2009 Nov 14;15(42):5279-86. doi: 10.3748/wjg.15.5279.
3
Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.血清高尔基糖蛋白-3在鉴别肝细胞癌与非恶性慢性肝病和其他肝癌中的诊断作用。
J Gastroenterol Hepatol. 2010 Jan;25(1):129-37. doi: 10.1111/j.1440-1746.2009.05988.x. Epub 2009 Sep 27.
4
Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patients.血清嗜铬粒蛋白 A(CgA)水平作为老年肝细胞癌(HCC)患者进展的标志物。
Arch Gerontol Geriatr. 2010 Jul-Aug;51(1):81-5. doi: 10.1016/j.archger.2009.08.004. Epub 2009 Sep 19.
5
The role of immunity in elderly cancer.免疫在老年癌症中的作用。
Crit Rev Oncol Hematol. 2010 Apr;74(1):40-60. doi: 10.1016/j.critrevonc.2009.06.002. Epub 2009 Jul 4.
6
Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.胆管癌患者血清基质金属蛋白酶-7和基质金属蛋白酶-9的检测:诊断准确性评估
BMC Gastroenterol. 2009 Apr 30;9:30. doi: 10.1186/1471-230X-9-30.
7
Serum and bile biomarkers for cholangiocarcinoma.胆管癌的血清和胆汁生物标志物。
Curr Opin Gastroenterol. 2009 May;25(3):279-84. doi: 10.1097/mog.0b013e328325a894.
8
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.基质金属蛋白酶在肝内胆管癌、肝门部(克氏壶腹肿瘤)、肝外胆管中下段癌、胆囊癌和壶腹癌中的表达:基质金属蛋白酶在肿瘤进展和预后中的作用
Turk J Gastroenterol. 2009 Mar;20(1):41-7.
9
Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma.胆管癌患者血清KL-6粘蛋白水平升高。
Hepatogastroenterology. 2008 Nov-Dec;55(88):2000-4.
10
Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha.环氧化酶-2参与肿瘤坏死因子-α诱导的胆管癌中基质金属蛋白酶-9的上调。
Am J Pathol. 2009 Mar;174(3):829-41. doi: 10.2353/ajpath.2009.080012. Epub 2009 Feb 13.

胆管肿瘤标志物。

Markers of bile duct tumors.

机构信息

Giulia Malaguarnera, Clorinda Mazzarino, Department of Biomedical Science, University of Catania, via Androne 83, 95124 Catania, Italy.

出版信息

World J Gastrointest Oncol. 2011 Apr 15;3(4):49-59. doi: 10.4251/wjgo.v3.i4.49.

DOI:10.4251/wjgo.v3.i4.49
PMID:21528090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3083496/
Abstract

Biliary tract carcinomas are relatively rare, representing less than 1% of cancers. However, their incidence has increased in Japan and in industrialized countries like the USA. Biliary tract tumors have a poor prognosis and a high mortality rate because they are usually detected late in the course of the disease; therapeutic treatment options are often limited and of minimal utility. Recent studies have shown the importance of serum and molecular markers in the diagnosis and follow up of biliary tract tumors. This review aims to introduce the main features of the most important serum and molecular markers of biliary tree tumors. Some considerable tumor markers are cancer antigen 125, carbohydrate antigen 19-9, carcinoembryonic antigen, chromogranin A, mucin 1, mucin 5, alpha-fetoprotein, claudins and cytokeratins.

摘要

胆道癌相对少见,占癌症的比例不到 1%。然而,在日本和美国等工业化国家,其发病率有所增加。胆道肿瘤预后不良,死亡率高,因为它们通常在疾病过程的晚期才被发现;治疗选择往往有限,效果甚微。最近的研究表明,血清和分子标志物在胆道肿瘤的诊断和随访中具有重要意义。本综述旨在介绍胆道肿瘤最重要的血清和分子标志物的主要特征。一些重要的肿瘤标志物有癌抗原 125、糖类抗原 19-9、癌胚抗原、嗜铬粒蛋白 A、黏蛋白 1、黏蛋白 5、甲胎蛋白、claudins 和细胞角蛋白。